SIRT1 and acute myeloid leukemia: Based on these studies, we hypothesized that chidamide might affect specific histone methylation (H3K9me3) levels in AML cells that is related to the prognosis of AML and that chidamide might inhibit autophagy by modulating the level of SIRT1.